Filing metadata

Accession number
0000950170-25-024485
Form type
Form 4
Filer
Vanda Pharmaceuticals Inc.
CIK
CIK 1347178
Filed
Feb 20, 2025
Reporting period
Feb 18, 2025
Description
Insider transaction

Explore SEC Filings Hub